The global Opioid Drugs market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oceania, South America).
By Market Verdors:
Acura Pharmaceuticals
Teva Pharmaceutical Industries Ltd.
Johnson＆Johnson
Cipher Pharmaceutical Inc.
Sun Pharmaceuticals
Daiichi Sankyo
Pfizer
Lupin Limited
By Types:
Buprenorphine
Fentanyl
Hydrocodone
Morphine
Oxycodone
Tramadol
Others
By Applications:
Anesthesia
Pain relief
Cough suppression
Diarrhea suppression
Deaddiction
Others
Key Indicators Analysed
Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2017-2028 & Sales with a thorough analysis of the market's competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2017-2028. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
Opportunities and Drivers: Identifying the Growing Demands and New Technology
Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
Key Reasons to Purchase
To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.
Assess the production processes, major issues, and solutions to mitigate the development risk.
To understand the most affecting driving and restraining forces in the market and its impact in the global market.
Learn about the market strategies that are being adopted by leading respective organizations.
To understand the future outlook and prospects for the market.
Besides the standard structure reports, we also provide custom research according to specific requirements.
Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.4.1 North America Market States and Outlook (2023-2028)
1.4.2 East Asia Market States and Outlook (2023-2028)
1.4.3 Europe Market States and Outlook (2023-2028)
1.4.4 South Asia Market States and Outlook (2023-2028)
1.4.5 Southeast Asia Market States and Outlook (2023-2028)
1.4.6 Middle East Market States and Outlook (2023-2028)
1.4.7 Africa Market States and Outlook (2023-2028)
1.4.8 Oceania Market States and Outlook (2023-2028)
1.4.9 South America Market States and Outlook (2023-2028)
1.5 Global Opioid Drugs Market Size Analysis from 2023 to 2028
1.5.1 Global Opioid Drugs Market Size Analysis from 2023 to 2028 by Consumption Volume
1.5.2 Global Opioid Drugs Market Size Analysis from 2023 to 2028 by Value
1.5.3 Global Opioid Drugs Price Trends Analysis from 2023 to 2028
1.6 COVID-19 Outbreak: Opioid Drugs Industry Impact
Chapter 2 Global Opioid Drugs Competition by Types, Applications, and Top Regions and Countries
2.1 Global Opioid Drugs (Volume and Value) by Type
2.1.1 Global Opioid Drugs Consumption and Market Share by Type (2017-2022)
2.1.2 Global Opioid Drugs Revenue and Market Share by Type (2017-2022)
2.2 Global Opioid Drugs (Volume and Value) by Application
2.2.1 Global Opioid Drugs Consumption and Market Share by Application (2017-2022)
2.2.2 Global Opioid Drugs Revenue and Market Share by Application (2017-2022)
2.3 Global Opioid Drugs (Volume and Value) by Regions
2.3.1 Global Opioid Drugs Consumption and Market Share by Regions (2017-2022)
2.3.2 Global Opioid Drugs Revenue and Market Share by Regions (2017-2022)
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.1.1 2017-2022 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis
3.1.2 2017-2022 Major Manufacturers Performance and Market Share
3.2 Regional Production Market Analysis
3.2.1 2017-2022 Regional Market Performance and Market Share
3.2.2 North America Market
3.2.3 East Asia Market
3.2.4 Europe Market
3.2.5 South Asia Market
3.2.6 Southeast Asia Market
3.2.7 Middle East Market
3.2.8 Africa Market
3.2.9 Oceania Market
3.2.10 South America Market
3.2.11 Rest of the World Market
Chapter 4 Global Opioid Drugs Sales, Consumption, Export, Import by Regions (2017-2022)
4.1 Global Opioid Drugs Consumption by Regions (2017-2022)
4.2 North America Opioid Drugs Sales, Consumption, Export, Import (2017-2022)
4.3 East Asia Opioid Drugs Sales, Consumption, Export, Import (2017-2022)
4.4 Europe Opioid Drugs Sales, Consumption, Export, Import (2017-2022)
4.5 South Asia Opioid Drugs Sales, Consumption, Export, Import (2017-2022)
4.6 Southeast Asia Opioid Drugs Sales, Consumption, Export, Import (2017-2022)
4.7 Middle East Opioid Drugs Sales, Consumption, Export, Import (2017-2022)
4.8 Africa Opioid Drugs Sales, Consumption, Export, Import (2017-2022)
4.9 Oceania Opioid Drugs Sales, Consumption, Export, Import (2017-2022)
4.10 South America Opioid Drugs Sales, Consumption, Export, Import (2017-2022)
Chapter 5 North America Opioid Drugs Market Analysis
5.1 North America Opioid Drugs Consumption and Value Analysis
5.1.1 North America Opioid Drugs Market Under COVID-19
5.2 North America Opioid Drugs Consumption Volume by Types
5.3 North America Opioid Drugs Consumption Structure by Application
5.4 North America Opioid Drugs Consumption by Top Countries
5.4.1 United States Opioid Drugs Consumption Volume from 2017 to 2022
5.4.2 Canada Opioid Drugs Consumption Volume from 2017 to 2022
5.4.3 Mexico Opioid Drugs Consumption Volume from 2017 to 2022
Chapter 6 East Asia Opioid Drugs Market Analysis
6.1 East Asia Opioid Drugs Consumption and Value Analysis
6.1.1 East Asia Opioid Drugs Market Under COVID-19
6.2 East Asia Opioid Drugs Consumption Volume by Types
6.3 East Asia Opioid Drugs Consumption Structure by Application
6.4 East Asia Opioid Drugs Consumption by Top Countries
6.4.1 China Opioid Drugs Consumption Volume from 2017 to 2022
6.4.2 Japan Opioid Drugs Consumption Volume from 2017 to 2022
6.4.3 South Korea Opioid Drugs Consumption Volume from 2017 to 2022
Chapter 7 Europe Opioid Drugs Market Analysis
7.1 Europe Opioid Drugs Consumption and Value Analysis
7.1.1 Europe Opioid Drugs Market Under COVID-19
7.2 Europe Opioid Drugs Consumption Volume by Types
7.3 Europe Opioid Drugs Consumption Structure by Application
7.4 Europe Opioid Drugs Consumption by Top Countries
7.4.1 Germany Opioid Drugs Consumption Volume from 2017 to 2022
7.4.2 UK Opioid Drugs Consumption Volume from 2017 to 2022
7.4.3 France Opioid Drugs Consumption Volume from 2017 to 2022
7.4.4 Italy Opioid Drugs Consumption Volume from 2017 to 2022
7.4.5 Russia Opioid Drugs Consumption Volume from 2017 to 2022
7.4.6 Spain Opioid Drugs Consumption Volume from 2017 to 2022
7.4.7 Netherlands Opioid Drugs Consumption Volume from 2017 to 2022
7.4.8 Switzerland Opioid Drugs Consumption Volume from 2017 to 2022
7.4.9 Poland Opioid Drugs Consumption Volume from 2017 to 2022
Chapter 8 South Asia Opioid Drugs Market Analysis
8.1 South Asia Opioid Drugs Consumption and Value Analysis
8.1.1 South Asia Opioid Drugs Market Under COVID-19
8.2 South Asia Opioid Drugs Consumption Volume by Types
8.3 South Asia Opioid Drugs Consumption Structure by Application
8.4 South Asia Opioid Drugs Consumption by Top Countries
8.4.1 India Opioid Drugs Consumption Volume from 2017 to 2022
8.4.2 Pakistan Opioid Drugs Consumption Volume from 2017 to 2022
8.4.3 Bangladesh Opioid Drugs Consumption Volume from 2017 to 2022
Chapter 9 Southeast Asia Opioid Drugs Market Analysis
9.1 Southeast Asia Opioid Drugs Consumption and Value Analysis
9.1.1 Southeast Asia Opioid Drugs Market Under COVID-19
9.2 Southeast Asia Opioid Drugs Consumption Volume by Types
9.3 Southeast Asia Opioid Drugs Consumption Structure by Application
9.4 Southeast Asia Opioid Drugs Consumption by Top Countries
9.4.1 Indonesia Opioid Drugs Consumption Volume from 2017 to 2022
9.4.2 Thailand Opioid Drugs Consumption Volume from 2017 to 2022
9.4.3 Singapore Opioid Drugs Consumption Volume from 2017 to 2022
9.4.4 Malaysia Opioid Drugs Consumption Volume from 2017 to 2022
9.4.5 Philippines Opioid Drugs Consumption Volume from 2017 to 2022
9.4.6 Vietnam Opioid Drugs Consumption Volume from 2017 to 2022
9.4.7 Myanmar Opioid Drugs Consumption Volume from 2017 to 2022
Chapter 10 Middle East Opioid Drugs Market Analysis
10.1 Middle East Opioid Drugs Consumption and Value Analysis
10.1.1 Middle East Opioid Drugs Market Under COVID-19
10.2 Middle East Opioid Drugs Consumption Volume by Types
10.3 Middle East Opioid Drugs Consumption Structure by Application
10.4 Middle East Opioid Drugs Consumption by Top Countries
10.4.1 Turkey Opioid Drugs Consumption Volume from 2017 to 2022
10.4.2 Saudi Arabia Opioid Drugs Consumption Volume from 2017 to 2022
10.4.3 Iran Opioid Drugs Consumption Volume from 2017 to 2022
10.4.4 United Arab Emirates Opioid Drugs Consumption Volume from 2017 to 2022
10.4.5 Israel Opioid Drugs Consumption Volume from 2017 to 2022
10.4.6 Iraq Opioid Drugs Consumption Volume from 2017 to 2022
10.4.7 Qatar Opioid Drugs Consumption Volume from 2017 to 2022
10.4.8 Kuwait Opioid Drugs Consumption Volume from 2017 to 2022
10.4.9 Oman Opioid Drugs Consumption Volume from 2017 to 2022
Chapter 11 Africa Opioid Drugs Market Analysis
11.1 Africa Opioid Drugs Consumption and Value Analysis
11.1.1 Africa Opioid Drugs Market Under COVID-19
11.2 Africa Opioid Drugs Consumption Volume by Types
11.3 Africa Opioid Drugs Consumption Structure by Application
11.4 Africa Opioid Drugs Consumption by Top Countries
11.4.1 Nigeria Opioid Drugs Consumption Volume from 2017 to 2022
11.4.2 South Africa Opioid Drugs Consumption Volume from 2017 to 2022
11.4.3 Egypt Opioid Drugs Consumption Volume from 2017 to 2022
11.4.4 Algeria Opioid Drugs Consumption Volume from 2017 to 2022
11.4.5 Morocco Opioid Drugs Consumption Volume from 2017 to 2022
Chapter 12 Oceania Opioid Drugs Market Analysis
12.1 Oceania Opioid Drugs Consumption and Value Analysis
12.2 Oceania Opioid Drugs Consumption Volume by Types
12.3 Oceania Opioid Drugs Consumption Structure by Application
12.4 Oceania Opioid Drugs Consumption by Top Countries
12.4.1 Australia Opioid Drugs Consumption Volume from 2017 to 2022
12.4.2 New Zealand Opioid Drugs Consumption Volume from 2017 to 2022
Chapter 13 South America Opioid Drugs Market Analysis
13.1 South America Opioid Drugs Consumption and Value Analysis
13.1.1 South America Opioid Drugs Market Under COVID-19
13.2 South America Opioid Drugs Consumption Volume by Types
13.3 South America Opioid Drugs Consumption Structure by Application
13.4 South America Opioid Drugs Consumption Volume by Major Countries
13.4.1 Brazil Opioid Drugs Consumption Volume from 2017 to 2022
13.4.2 Argentina Opioid Drugs Consumption Volume from 2017 to 2022
13.4.3 Columbia Opioid Drugs Consumption Volume from 2017 to 2022
13.4.4 Chile Opioid Drugs Consumption Volume from 2017 to 2022
13.4.5 Venezuela Opioid Drugs Consumption Volume from 2017 to 2022
13.4.6 Peru Opioid Drugs Consumption Volume from 2017 to 2022
13.4.7 Puerto Rico Opioid Drugs Consumption Volume from 2017 to 2022
13.4.8 Ecuador Opioid Drugs Consumption Volume from 2017 to 2022
Chapter 14 Company Profiles and Key Figures in Opioid Drugs Business
14.1 Acura Pharmaceuticals
14.1.1 Acura Pharmaceuticals Company Profile
14.1.2 Acura Pharmaceuticals Opioid Drugs Product Specification
14.1.3 Acura Pharmaceuticals Opioid Drugs Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.2 Teva Pharmaceutical Industries Ltd.
14.2.1 Teva Pharmaceutical Industries Ltd. Company Profile
14.2.2 Teva Pharmaceutical Industries Ltd. Opioid Drugs Product Specification
14.2.3 Teva Pharmaceutical Industries Ltd. Opioid Drugs Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.3 Johnson＆Johnson
14.3.1 Johnson＆Johnson Company Profile
14.3.2 Johnson＆Johnson Opioid Drugs Product Specification
14.3.3 Johnson＆Johnson Opioid Drugs Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.4 Cipher Pharmaceutical Inc.
14.4.1 Cipher Pharmaceutical Inc. Company Profile
14.4.2 Cipher Pharmaceutical Inc. Opioid Drugs Product Specification
14.4.3 Cipher Pharmaceutical Inc. Opioid Drugs Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.5 Sun Pharmaceuticals
14.5.1 Sun Pharmaceuticals Company Profile
14.5.2 Sun Pharmaceuticals Opioid Drugs Product Specification
14.5.3 Sun Pharmaceuticals Opioid Drugs Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.6 Daiichi Sankyo
14.6.1 Daiichi Sankyo Company Profile
14.6.2 Daiichi Sankyo Opioid Drugs Product Specification
14.6.3 Daiichi Sankyo Opioid Drugs Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.7 Pfizer
14.7.1 Pfizer Company Profile
14.7.2 Pfizer Opioid Drugs Product Specification
14.7.3 Pfizer Opioid Drugs Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.8 Lupin Limited
14.8.1 Lupin Limited Company Profile
14.8.2 Lupin Limited Opioid Drugs Product Specification
14.8.3 Lupin Limited Opioid Drugs Production Capacity, Revenue, Price and Gross Margin (2017-2022)
Chapter 15 Global Opioid Drugs Market Forecast (2023-2028)
15.1 Global Opioid Drugs Consumption Volume, Revenue and Price Forecast (2023-2028)
15.1.1 Global Opioid Drugs Consumption Volume and Growth Rate Forecast (2023-2028)
15.1.2 Global Opioid Drugs Value and Growth Rate Forecast (2023-2028)
15.2 Global Opioid Drugs Consumption Volume, Value and Growth Rate Forecast by Region (2023-2028)
15.2.1 Global Opioid Drugs Consumption Volume and Growth Rate Forecast by Regions (2023-2028)
15.2.2 Global Opioid Drugs Value and Growth Rate Forecast by Regions (2023-2028)
15.2.3 North America Opioid Drugs Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.4 East Asia Opioid Drugs Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.5 Europe Opioid Drugs Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.6 South Asia Opioid Drugs Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.7 Southeast Asia Opioid Drugs Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.8 Middle East Opioid Drugs Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.9 Africa Opioid Drugs Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.10 Oceania Opioid Drugs Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.11 South America Opioid Drugs Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.3 Global Opioid Drugs Consumption Volume, Revenue and Price Forecast by Type (2023-2028)
15.3.1 Global Opioid Drugs Consumption Forecast by Type (2023-2028)
15.3.2 Global Opioid Drugs Revenue Forecast by Type (2023-2028)
15.3.3 Global Opioid Drugs Price Forecast by Type (2023-2028)
15.4 Global Opioid Drugs Consumption Volume Forecast by Application (2023-2028)
15.5 Opioid Drugs Market Forecast Under COVID-19
Chapter 16 Conclusions
Research Methodology
| Price : US$ 2450 |
Date : Apr 2024 |
| Category : Electronics |
Pages : 269 |
| Price : US$ 2450 |
Date : Feb 2024 |
| Category : Electronics |
Pages : 261 |
Request Sample 
Request Discount 
Inquire Before Buy
